Background The 69th World Health Assembly approved the Global Health Sector Strategy
to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the …

Background Since the release of the first global hepatitis elimination targets in 2016, and until
the COVID-19 pandemic started in early 2020, many countries and territories were making …

Liver disease in the UK stands out as the one glaring exception to the vast improvements
made during the past 30 years in health and life expectancy for chronic disorders such as …

Natural killer (NK) cells provide a central defense against viral infection by using inhibitory
and activation receptors for major histocompatibility complex class I molecules as a means of …

The disease burden of hepatitis C virus ( HCV ) is expected to increase as the infected population
ages. A modelling approach was used to estimate the total number of viremic infections…

BACKGROUND: Few studies have reported the biomechanical aspects of stair climbing for
this ergonomically demanding task. The purpose of this ethically approved study was to …

The biochemical response to ursodeoxycholic acid (UDCA)—so‐called “treatment response”—strongly
predicts long‐term outcome in primary biliary cholangitis (PBC). Several long‐…

Chronic infection with hepatitis C virus (HCV) is a leading indicator for liver disease. New
treatment options are becoming available, and there is a need to characterize the …

Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and
mortality worldwide. In the European Union (EU), treatment and cure of HCV with direct-acting …

The number of hepatitis C virus ( HCV ) infections is projected to decline while those with
advanced liver disease will increase. A modeling approach was used to forecast two treatment …